Brukinsa (zanubrutinib) — Highmark
quantity limit exception
Initial criteria
- additional quantities up to 8 capsules per day (80 mg) or up to 4 tablets per day (160 mg) may be approved when the member is taking a moderate CYP3A inducer
Approval duration
12 months